GABARAP and prostate carcinoma: In 2016, Engedal et al. proved that GABARAP-subfamily proteins are strongly involved in autophagy mechanisms in prostate cancer [8], supporting the idea that GABARAP inhibitors could be valuable tools to fight the progression of this disease.